Integrating multi-modal imaging in radiation treatments for glioblastoma
Neuro-Oncology · 04.03.2024 · 26 (Supplement_1) · S17-S25
DOI: 10.1093/neuonc/noad187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, online erschienen am 04.03.2024. Verfasst von William G Breen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Glioblastoma, Radiation Oncology. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NCI.
Abstract (Originalsprache)
Advances in diagnostic and treatment technology along with rapid developments in translational research may now allow the realization of precision radiotherapy. Integration of biologically informed multimodality imaging to address the spatial and temporal heterogeneity underlying treatment resistance in glioblastoma is now possible for patient care, with evidence of safety and potential benefit. Beyond their diagnostic utility, several candidate imaging biomarkers have emerged in recent early-phase clinical trials of biologically based radiotherapy, and their definitive assessment in multicenter prospective trials is already in development. In this review, the rationale for clinical implementation of candidate advanced magnetic resonance imaging and positron emission tomography imaging biomarkers to guide personalized radiotherapy, the current landscape, and future directions for integrating imaging biomarkers into radiotherapy for glioblastoma are summarized. Moving forward, response-adaptive radiotherapy using biologically informed imaging biomarkers to address emerging treatment resistance in rational combination with novel systemic therapies may ultimately permit improvements in glioblastoma outcomes and true individualization of patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Michelle M Kim
Förderung
- NCI NIH HHS
- NIH HHS
- NCI
- National Institutes of Health
Zitieren
APA
Breen, W. G., Aryal, M. P., Cao, Y., & Kim, M. M. (2024). Integrating multi-modal imaging in radiation treatments for glioblastoma. Neuro-Oncology, 26(Supplement_1), S17-S25. https://doi.org/10.1093/neuonc/noad187
Vancouver
Breen WG, Aryal MP, Cao Y, Kim MM. Integrating multi-modal imaging in radiation treatments for glioblastoma. Neuro-Oncology. 2024;26(Supplement_1):S17-S25. doi:10.1093/neuonc/noad187
BibTeX
@article{Breen2024,
author = {Breen, William G and Aryal, Madhava P and Cao, Yue and Kim, Michelle M},
title = {Integrating multi-modal imaging in radiation treatments for glioblastoma},
journal = {Neuro-Oncology},
year = {2024},
volume = {26},
number = {Supplement_1},
pages = {S17--S25},
doi = {10.1093/neuonc/noad187}
}
EUVIMED